环环酸盐用于高血症.
Aafreen Shaikh1, Claire Stark Toller2
1Mountbatten Hampshire, Southampton, UK.
BMJ supportive & palliative care
|December 5, 2023
概括
高血症是一种严重的疾病,现在可以在临床医院中进行非侵入性治疗. 口服的氧化环酸盐提供了一个美味的选择,可能改善患者的生活质量.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
背景情况:
- 超血是需要住院治疗的临界医疗紧急情况.
- 目前的治疗方法往往不适合宿舍患者.
- 需要在息护理环境中进行有效的,非侵入性的高血症管理.
研究的目的:
- 报告一种口服氧化环酸盐在住院患者中使用过高血症的病例.
- 评估这种治疗在息护理环境中的耐受性和潜在疗效.
主要方法:
- 一名患有高血症的住院病人接受了口服氧环酸盐治疗.
- 治疗是非侵入性地进行的.
- 对患者的耐受性和临床结果进行了监测.
主要成果:
- 口服的硫环酸盐被患者耐受得很好.
- 治疗可能有助于长期 (两周) 的良好生活质量.
- 这种非侵入性方法在宿舍环境中证明了可行性.
结论:
- 口服的硫环酸盐是临终关怀中高血症的潜在非侵入性治疗选择.
- 这一案例凸显了改善患有高血症的息治疗患者生活质量的可能性.
- 需要进一步的研究来证实这种方法在类似环境中的有效性和安全性.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
582
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
582
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antihypertensive Drugs: Thiazide-Class Diuretics
680
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
680
Qualitative Analysis
22.4K
For solutions containing mixtures of different cations, the identity of each cation can be determined by qualitative analysis. This technique involves a series of selective precipitations with different chemical reagents, each reaction producing a characteristic precipitate for a specific group of cations. Metal ions within a group are further separated by varying the pH, heating the mixture to redissolve a precipitate, or adding other reagents to form complex ions.
For instance, group IV...
For instance, group IV...
22.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiepileptic Drugs: Potassium Channel Activators
186
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
186


